Health Canada drug identification number

DIN 02384892 — TEVA-NABILONE 1.0 MG

TEVA-NABILONE is a capsule of Nabilone marketed by TEVA CANADA LIMITED. The full Nabilone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02384892
Brand name
TEVA-NABILONE
Active ingredient
Nabilone
Strength
1.0 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
TEVA CANADA LIMITED
Health Canada status
MARKETED
Drug class
Synthetic cannabinoid (antiemetic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Nabilone products

DINBrandStrengthFormManufacturerStatus
02312263 CESAMET 0.25 MG CAPSULE BAUSCH HEALTH, CANADA INC. MARKETED
02256193 CESAMET 0.5 MG CAPSULE BAUSCH HEALTH, CANADA INC. MARKETED
00548375 CESAMET 1 MG CAPSULE BAUSCH HEALTH, CANADA INC. MARKETED
02380897 PMS-NABILONE 0.25 MG CAPSULE PHARMASCIENCE INC MARKETED
02380900 PMS-NABILONE 0.5 MG CAPSULE PHARMASCIENCE INC MARKETED
02380919 PMS-NABILONE 1.0 MG CAPSULE PHARMASCIENCE INC MARKETED
02392925 TEVA-NABILONE 0.25 MG CAPSULE TEVA CANADA LIMITED MARKETED
02384884 TEVA-NABILONE 0.5 MG CAPSULE TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.